TAVALISSE First and Only SYK Inhibitor for Immune Thrombocytopenia (ITP) ~ 6/9/22 @ Morton'sSocial Media CoordinatorApr 27, 20220 min read53420_Invitation_v1.pdfDownload PDF • 529KB
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
NEW EVENT! Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses ~ March 19th, 2025 at Joe's on Newbury
Comments